Ines Primožič

978 total citations
52 papers, 836 citations indexed

About

Ines Primožič is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Ines Primožič has authored 52 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Organic Chemistry, 23 papers in Pharmacology and 20 papers in Molecular Biology. Recurrent topics in Ines Primožič's work include Cholinesterase and Neurodegenerative Diseases (22 papers), Computational Drug Discovery Methods (15 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (8 papers). Ines Primožič is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (22 papers), Computational Drug Discovery Methods (15 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (8 papers). Ines Primožič collaborates with scholars based in Croatia, China and Israel. Ines Primožič's co-authors include Tomica Hrenar, Nada Filipović-Vinceković, Maja Dutour Sikirić, Srđanka Tomić, Zrinka Kovarik, Ozren Jović, Vera Simeon-Rudolf, Maja Katalinić, Y. Talmon and Maja Majerić Elenkov and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and The Journal of Physical Chemistry B.

In The Last Decade

Ines Primožič

50 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ines Primožič Croatia 18 449 267 208 177 141 52 836
Rachid Baati France 20 633 1.4× 591 2.2× 329 1.6× 674 3.8× 102 0.7× 66 1.6k
Joanna Matysiak Poland 21 1.1k 2.4× 158 0.6× 396 1.9× 60 0.3× 200 1.4× 88 1.5k
Vyacheslav E. Semenov Russia 18 765 1.7× 191 0.7× 423 2.0× 73 0.4× 130 0.9× 133 1.2k
Julio A. Seijas Spain 23 917 2.0× 181 0.7× 368 1.8× 93 0.5× 23 0.2× 98 1.8k
Marianne Koller Germany 19 184 0.4× 320 1.2× 172 0.8× 794 4.5× 57 0.4× 44 1.2k
Rudolf Kiralj Brazil 15 246 0.5× 54 0.2× 177 0.9× 54 0.3× 329 2.3× 41 762
Mustafa Küçükislamoğlu Türkiye 17 545 1.2× 201 0.8× 326 1.6× 112 0.6× 112 0.8× 42 1.0k
Veronika Opletalová Czechia 20 480 1.1× 429 1.6× 203 1.0× 260 1.5× 173 1.2× 52 960
Jean‐François Gallard France 19 311 0.7× 183 0.7× 429 2.1× 160 0.9× 24 0.2× 61 998
Ján Imrich Slovakia 22 921 2.1× 223 0.8× 762 3.7× 137 0.8× 143 1.0× 110 1.6k

Countries citing papers authored by Ines Primožič

Since Specialization
Citations

This map shows the geographic impact of Ines Primožič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Primožič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Primožič more than expected).

Fields of papers citing papers by Ines Primožič

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ines Primožič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Primožič. The network helps show where Ines Primožič may publish in the future.

Co-authorship network of co-authors of Ines Primožič

This figure shows the co-authorship network connecting the top 25 collaborators of Ines Primožič. A scholar is included among the top collaborators of Ines Primožič based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ines Primožič. Ines Primožič is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Primožič, Ines, et al.. (2025). Cholinesterase activity modulators: Evaluation of dodecylaminoquinuclidines as inhibitors of human AChE and BChE. Chemico-Biological Interactions. 417. 111567–111567.
2.
Primožič, Ines, et al.. (2024). Naturally derived 3-aminoquinuclidine salts as new promising therapeutic agents. Scientific Reports. 14(1). 26211–26211. 1 indexed citations
3.
Primožič, Ines, et al.. (2023). Synthesis and Biological Evaluation of 3-Amidoquinuclidine Quaternary Ammonium Compounds as New Soft Antibacterial Agents. Pharmaceuticals. 16(2). 187–187. 4 indexed citations
4.
5.
Brkljača, Zlatko, et al.. (2022). New Membrane Active Antibacterial and Antiviral Amphiphiles Derived from Heterocyclic Backbone of Pyridinium-4-Aldoxime. Pharmaceuticals. 15(7). 775–775. 3 indexed citations
6.
Skočibušić, Mirjana, et al.. (2021). Antimicrobial Activity of Quasi-Enantiomeric Cinchona Alkaloid Derivatives and Prediction Model Developed by Machine Learning. Antibiotics. 10(6). 659–659. 10 indexed citations
7.
Katalinić, Maja, et al.. (2020). Targeting organophosphorus compounds poisoning by novel quinuclidine-3 oximes: development of butyrylcholinesterase-based bioscavengers. Archives of Toxicology. 94(9). 3157–3171. 29 indexed citations
8.
Skočibušić, Mirjana, et al.. (2018). Novel Imidazole Aldoximes with Broad-Spectrum Antimicrobial Potency against Multidrug Resistant Gram-Negative Bacteria. Molecules. 23(5). 1212–1212. 11 indexed citations
9.
Maravić, Ana, Barbara Soldo, Viljemka Bučević‐Popović, et al.. (2018). Discovery of novel quaternary ammonium compounds based on quinuclidine-3-ol as new potential antimicrobial candidates. European Journal of Medicinal Chemistry. 163. 626–635. 47 indexed citations
10.
Vrdoljak, Višnja, Biserka Prugovečki, Ines Primožič, et al.. (2018). An integrated approach (synthetic, structural and biological) to the study of aroylhydrazone salts. New Journal of Chemistry. 42(14). 11697–11707. 3 indexed citations
11.
Bosak, Anita, et al.. (2018). Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold. PLoS ONE. 13(10). e0205193–e0205193. 28 indexed citations
12.
Skočibušić, Mirjana, Zoran Štefanić, Ozren Jović, et al.. (2015). Structure–property relationship of quinuclidinium surfactants—Towards multifunctional biologically active molecules. Colloids and Surfaces B Biointerfaces. 140. 548–559. 21 indexed citations
13.
Hrenar, Tomica, et al.. (2014). Using synergy of experimental and computational techniques to solve monomer–trimer dilemma. Powder Diffraction. 30(S1). S36–S40. 4 indexed citations
14.
Primožič, Ines, et al.. (2007). 3-amidoquinuclidine derivatives : Synthesis and interaction with butyrylcholinesterase. Croatica Chemica Acta. 80(1). 101–107. 4 indexed citations
15.
Čalić, Maja, et al.. (2006). Evaluation of monoquaternary pyridinium oximes potency to reactivate tabun-inhibited human acetylcholinesterase. Toxicology. 233(1-3). 85–96. 39 indexed citations
16.
Bosak, Anita, et al.. (2005). Enantiomers of quinuclidin-3-ol derivatives: resolution and interactions with human cholinesterases. Croatica Chemica Acta. 78(1). 121–128. 20 indexed citations
17.
Simeon-Rudolf, Vera, et al.. (2005). (41) Preparation of enantiomers of quinuclidin-3-Ol derivatives and their interactions with human cholinesterases. Chemico-Biological Interactions. 157-158. 420–421. 8 indexed citations
18.
Primožič, Ines, Tomica Hrenar, Srđanka Tomić, & Zlatko Meić. (2003). Structural Basis for Selectivity of Butyrylcholinesterase towards Enantiomeric Quinuclidin-3-yl Benzoates: a Quantum Chemical Study. Croatica Chemica Acta. 76(1). 93–99. 7 indexed citations
19.
Simeon-Rudolf, Vera, Elsa Reiner, Božica Radić, et al.. (1998). Quinuclidinium-imidazolium compounds: synthesis, mode of interaction with acetylcholinesterase and effect upon Soman intoxicated mice. Archives of Toxicology. 72(5). 289–295. 26 indexed citations
20.
Tomić-Lučić, Aleksandra, et al.. (1997). Antidotal efficacy of quinuclidinium oximes against soman poisoning. Archives of Toxicology. 71(7). 467–470. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachid Baati Breakdown of academic impact, for papers by Joanna Matysiak Breakdown of academic impact, for papers by Vyacheslav E. Semenov Breakdown of academic impact, for papers by Julio A. Seijas Breakdown of academic impact, for papers by Marianne Koller Breakdown of academic impact, for papers by Rudolf Kiralj Breakdown of academic impact, for papers by Mustafa Küçükislamoğlu Breakdown of academic impact, for papers by Veronika Opletalová Breakdown of academic impact, for papers by Jean‐François Gallard Breakdown of academic impact, for papers by Ján Imrich
Rankless by CCL
2026